Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ferdinandos Skoulidis
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
325 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim
Anaheim, California, United States
- Kaiser Permanente-Baldwin Park
Baldwin Park, California, United States
- Kaiser Permanente-Bellflower
Bellflower, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Kaiser Permanente-Fontana
Fontana, California, United States
- Palo Alto Medical Foundation-Fremont
Fremont, California, United States
- Kaiser Permanente-Fresno
Fresno, California, United States
- Kaiser Permanente - Harbor City
Harbor City, California, United States
- Kaiser Permanente-Irvine
Irvine, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente-Cadillac
Los Angeles, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Kaiser Permanente-Riverside
Riverside, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- Kaiser Permanente Downtown Commons
Sacramento, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Kaiser Permanente-San Diego Zion
San Diego, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, United States
- Kaiser Permanente San Leandro
San Leandro, California, United States
- Kaiser Permanente-San Marcos
San Marcos, California, United States
- Kaiser San Rafael-Gallinas
San Rafael, California, United States
- Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
- Palo Alto Medical Foundation-Santa Cruz
Santa Cruz, California, United States
- Kaiser Permanente-South San Francisco
South San Francisco, California, United States
- Palo Alto Medical Foundation-Sunnyvale
Sunnyvale, California, United States
- Kaiser Permanente-Vallejo
Vallejo, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- Kaiser Permanente-Walnut Creek
Walnut Creek, California, United States
- Presbyterian Intercommunity Hospital
Whittier, California, United States
- Kaiser Permanente-Woodland Hills
Woodland Hills, California, United States
- Rocky Mountain Cancer Centers-Aurora
Aurora, Colorado, United States
- University of Colorado Hospital
Aurora, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Feb 2020
- Primary completion
- 24 Nov 2021
- Completion
- 1 May 2024
- Last update posted
- 3 Sept 2024
- Registered enrollment
- 47
- Registry id
- NCT04173507
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.